Healthcare provider profile · identity verified

John E Mauer, MD

Internal Medicine · KETTERING, OH · NPI 1407812829

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	547	171
Atorvastatin Calcium	Atorvastatin Calcium	535	203
Amlodipine Besylate	Amlodipine Besylate	534	193
Losartan Potassium	Losartan Potassium	462	143
Lisinopril	Lisinopril	279	99
Omeprazole	Omeprazole	244	90
Gabapentin	Gabapentin	228	83
Sertraline Hcl	Sertraline Hcl	219	59
Metformin Hcl	Metformin Hcl	201	73
Tamsulosin Hcl	Tamsulosin Hcl	192	67
Tramadol Hcl	Tramadol Hcl	165	39
Furosemide	Furosemide	161	55
Jardiance	Empagliflozin	148	38
Simvastatin	Simvastatin	148	57
Carvedilol	Carvedilol	147	55
Pantoprazole Sodium	Pantoprazole Sodium	132	53
Eliquis	Apixaban	129	35
Zolpidem Tartrate	Zolpidem Tartrate	126	32
Rosuvastatin Calcium	Rosuvastatin Calcium	123	47
Lorazepam	Lorazepam	115	32
Trazodone Hcl	Trazodone Hcl	114	43
Alendronate Sodium	Alendronate Sodium	113	40
Ezetimibe	Ezetimibe	102	34
Hydroxyzine Hcl	Hydroxyzine Hcl	102	25
Potassium Chloride	Potassium Chloride	102	39
Metoprolol Tartrate	Metoprolol Tartrate	101	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	95	23
Synthroid	Levothyroxine Sodium	90	30
Allopurinol	Allopurinol	87	29
Clopidogrel	Clopidogrel Bisulfate	86	29
Hydralazine Hcl	Hydralazine Hcl	86	35
Januvia	Sitagliptin Phosphate	86	29
Duloxetine Hcl	Duloxetine Hcl	84	32
Pravastatin Sodium	Pravastatin Sodium	84	35
Hydrochlorothiazide	Hydrochlorothiazide	81	34
Glipizide	Glipizide	73	22
Metoprolol Succinate	Metoprolol Succinate	72	32
Bupropion Xl	Bupropion Hcl	71	21
Donepezil Hcl	Donepezil Hcl	70	21
Fluoxetine Hcl	Fluoxetine Hcl	70	17
Spironolactone	Spironolactone	70	25
Prednisone	Prednisone	69	36
Methylprednisolone	Methylprednisolone	68	60
Ozempic	Semaglutide	68	17
Metformin Hcl Er	Metformin Hcl	65	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	25
Escitalopram Oxalate	Escitalopram Oxalate	60	25
Memantine Hcl	Memantine Hcl	59	16
Albuterol Sulfate Hfa	Albuterol Sulfate	56	27
Esomeprazole Magnesium	Esomeprazole Magnesium	56	15
Famotidine	Famotidine	56	15
Farxiga	Dapagliflozin Propanediol	54	11
Fluticasone Propionate	Fluticasone Propionate	53	21
Mounjaro	Tirzepatide	52	11
Alprazolam	Alprazolam	50	12
Doxycycline Hyclate	Doxycycline Hyclate	50	44
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	50	39
Clonazepam	Clonazepam	49	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	14
Methocarbamol	Methocarbamol	48	19
Mirtazapine	Mirtazapine	48	23
Triamcinolone Acetonide	Triamcinolone Acetonide	48	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	16
Citalopram Hbr	Citalopram Hydrobromide	45	14
Trulicity	Dulaglutide	45	11
Ondansetron Odt	Ondansetron	44	15
Tizanidine Hcl	Tizanidine Hcl	43	11
Azithromycin	Azithromycin	42	39
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	38
Diazepam	Diazepam	41	12
Montelukast Sodium	Montelukast Sodium	41	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Rybelsus	Semaglutide	37	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	13
Buspirone Hcl	Buspirone Hcl	33	suppressed
Meclizine Hcl	Meclizine Hcl	31	18
Atenolol	Atenolol	30	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	16
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Finasteride	Finasteride	29	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	20
Terazosin Hcl	Terazosin Hcl	29	11
Amoxicillin	Amoxicillin	28	24
Irbesartan	Irbesartan	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	15
Paroxetine Hcl	Paroxetine Hcl	27	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	24
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Fenofibrate	Fenofibrate	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	12
Fenofibrate	Fenofibrate Nanocrystallized	24	suppressed
Meloxicam	Meloxicam	24	11
Nystatin	Nystatin	24	13
Candesartan Cilexetil	Candesartan Cilexetil	22	suppressed
Promethazine Hcl	Promethazine Hcl	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	20
Xarelto	Rivaroxaban	21	suppressed
Klor-Con M20	Potassium Chloride	20	suppressed
Valsartan	Valsartan	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Cephalexin	Cephalexin	18	13
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Glimepiride	Glimepiride	18	suppressed
Topiramate	Topiramate	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Testosterone	Testosterone	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	16
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Estradiol	Estradiol	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Ramipril	Ramipril	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Oxymorphone Hcl Er	Oxymorphone Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Cevimeline Hcl	Cevimeline Hcl	11	suppressed
Dexlansoprazole Dr	Dexlansoprazole	11	suppressed
Estradiol (Twice Weekly)	Estradiol	11	suppressed
Lagevrio (Eua)	Molnupiravir	11	11
Linzess	Linaclotide	11	suppressed
Metolazone	Metolazone	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Primidone	Primidone	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed
Valtrex	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error